Literature DB >> 20227323

Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.

Victoria E Shaw1, Kevin A Keay, Keyoumars Ashkan, Alim-Louis Benabid, John Mitrofanis.   

Abstract

In this anatomical study, we have examined the number of tyrosine hydroxylase (TH) cells in the periaqueductal grey matter (PAG) of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys and mice; further, we explored whether kainic acid lesion or deep brain stimulation (DBS) of the subthalamic nucleus (STN) in MPTP-treated monkeys has any impact on the number of TH(+) cells in the PAG. For monkeys, there were four groups: Normal, MPTP, STN-lesioned (+MPTP) and STN-DBS (+MPTP). For mice, BALB/c albino mice were divided into three groups, Saline, MPTP_50 (50 mg/kg), MPTP_100 (100 mg/kg). Animals were perfused transcardially with aldehyde fixative 6-12 days after their last MPTP injection. Brains were processed for immunochemistry and the number of cells was estimated using the optical fractionator method. Our results revealed significant reductions (25-30%) in TH(+) cell number in the PAG of MPTP-treated monkeys and mice compared to controls. These reductions were not as substantial as those recorded in the SNc in the same animals (40-60%). Further, in monkeys, there were significantly more TH(+) cells in the PAG of STN-lesioned and STN-DBS groups compared to the MPTP group. In fact, the number of TH(+) cells in the STN alteration cases were similar to the Normal group. In summary, our results indicated that MPTP is toxic to TH(+) cells in the PAG of monkeys and mice and that in monkeys, lesion or DBS of the STN offers neuroprotection against this toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227323     DOI: 10.1016/j.parkreldis.2010.02.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

Review 1.  Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends.

Authors:  Namgue Hong
Journal:  Biomed Eng Lett       Date:  2019-06-12

2.  Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease.

Authors:  Gian Pal; Bichun Ouyang; Leo Verhagen; Geidy Serrano; Holly A Shill; Charles H Adler; Thomas G Beach; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2018-01-30       Impact factor: 10.338

Review 3.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

Review 4.  Current application and future directions of photobiomodulation in central nervous diseases.

Authors:  Muyue Yang; Zhen Yang; Pu Wang; Zhihui Sun
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

5.  Survival of Dopaminergic Amacrine Cells after Near-Infrared Light Treatment in MPTP-Treated Mice.

Authors:  Cassandra Peoples; Victoria E Shaw; Jonathan Stone; Glen Jeffery; Gary E Baker; John Mitrofanis
Journal:  ISRN Neurol       Date:  2012-05-30

Review 6.  An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.

Authors:  Andrea Terron; Anna Bal-Price; Alicia Paini; Florianne Monnet-Tschudi; Susanne Hougaard Bennekou; Marcel Leist; Stefan Schildknecht
Journal:  Arch Toxicol       Date:  2017-12-05       Impact factor: 5.153

7.  Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation.

Authors:  Brian Lau; Niklaus Meier; Giulia Serra; Virginie Czernecki; Michael Schuepbach; Soledad Navarro; Philippe Cornu; David Grabli; Yves Agid; Marie Vidailhet; Carine Karachi; Marie-Laure Welter
Journal:  Neurology       Date:  2019-05-01       Impact factor: 9.910

8.  Deep brain stimulation in Parkinson's disease.

Authors:  Raja Mehanna; Eugene C Lai
Journal:  Transl Neurodegener       Date:  2013-11-18       Impact factor: 8.014

Review 9.  Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease.

Authors:  Daniel M Johnstone; Cécile Moro; Jonathan Stone; Alim-Louis Benabid; John Mitrofanis
Journal:  Front Neurosci       Date:  2016-01-11       Impact factor: 4.677

10.  Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?

Authors:  Ruth-Mary deSouza; Elena Moro; Anthony E Lang; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2013-05       Impact factor: 10.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.